Challenges in IgA Nephropathy Management: An Era of Complement Inhibition
Open Access
- 21 June 2023
- journal article
- review article
- Published by Elsevier in Kidney International Reports
- Vol. 8 (9) , 1730-1740
Abstract
No abstract availableKeywords
Funding Information
- Novartis Pharmaceuticals Corporation
This publication has 77 references indexed in Scilit:
- Association of C1q deposition with renal outcomes in IgA nephropathyClinical Nephrology, 2013
- Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathyClinical and Experimental Immunology, 2013
- Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal functionBMC Nephrology, 2011
- The Pathophysiology of IgA NephropathyJournal of the American Society of Nephrology, 2011
- The incidence of primary glomerulonephritis worldwide: a systematic review of the literatureNephrology Dialysis Transplantation, 2010
- Levels of Urinary Complement Factor H in Patients with IgA Nephropathy are Closely Associated with Disease ActivityScandinavian Journal of Immunology, 2009
- Glomerular Activation of the Lectin Pathway of Complement in IgA Nephropathy Is Associated with More Severe Renal DiseaseJournal of the American Society of Nephrology, 2006
- ComplementNew England Journal of Medicine, 2001
- Significance of Glomerular Deposition of C3c and C3d in IgA NephropathyAmerican Journal of Nephrology, 2000
- Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.Journal of Clinical Investigation, 1986